289 related articles for article (PubMed ID: 34164627)
41. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
42. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
43. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
[TBL] [Abstract][Full Text] [Related]
44. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
[TBL] [Abstract][Full Text] [Related]
45. Vaccines for immunoprevention of DNA mismatch repair deficient cancers.
Hernandez-Sanchez A; Grossman M; Yeung K; Sei SS; Lipkin S; Kloor M
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732349
[TBL] [Abstract][Full Text] [Related]
46. Efficient and allele-specific genome editing of disease loci in human iPSCs.
Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
[TBL] [Abstract][Full Text] [Related]
47. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
48. Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.
Davies H; Morganella S; Purdie CA; Jang SJ; Borgen E; Russnes H; Glodzik D; Zou X; Viari A; Richardson AL; Børresen-Dale AL; Thompson A; Eyfjord JE; Kong G; Stratton MR; Nik-Zainal S
Cancer Res; 2017 Sep; 77(18):4755-4762. PubMed ID: 28904067
[TBL] [Abstract][Full Text] [Related]
49. Background Mutational Features of the Radiation-Resistant Bacterium Deinococcus radiodurans.
Long H; Kucukyildirim S; Sung W; Williams E; Lee H; Ackerman M; Doak TG; Tang H; Lynch M
Mol Biol Evol; 2015 Sep; 32(9):2383-92. PubMed ID: 25976352
[TBL] [Abstract][Full Text] [Related]
50. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
Díaz-Gay M; Alexandrov LB
Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
[TBL] [Abstract][Full Text] [Related]
51. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.
Smith C; Gore A; Yan W; Abalde-Atristain L; Li Z; He C; Wang Y; Brodsky RA; Zhang K; Cheng L; Ye Z
Cell Stem Cell; 2014 Jul; 15(1):12-3. PubMed ID: 24996165
[No Abstract] [Full Text] [Related]
52. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
53. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
54. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.
Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B
Mod Pathol; 2021 May; 34(5):994-1007. PubMed ID: 33328602
[TBL] [Abstract][Full Text] [Related]
55. Generation of a gene corrected human isogenic iPSC line (CPGHi002-A-1) from a DDOD patient with heterozygous c.1516 C>T mutation in the ATP6V1B2 gene.
Gao X; Qiu SW; Wang WQ; Kang DY; Su N; Dai P; Yuan YY
Stem Cell Res; 2021 May; 53():102271. PubMed ID: 33714068
[TBL] [Abstract][Full Text] [Related]
56. Harnessing CRISPR-Cas systems for bacterial genome editing.
Selle K; Barrangou R
Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
[TBL] [Abstract][Full Text] [Related]
57. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD;
J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
59. Germline and Tumor Sequencing as a Diagnostic Tool To Resolve Suspected Lynch Syndrome.
Pope BJ; Clendenning M; Rosty C; Mahmood K; Georgeson P; Joo JE; Walker R; Hutchinson RA; Jayasekara H; Joseland S; Como J; Preston S; Spurdle AB; Macrae FA; Win AK; Hopper JL; Jenkins MA; Winship IM; Buchanan DD
J Mol Diagn; 2021 Mar; 23(3):358-371. PubMed ID: 33383211
[TBL] [Abstract][Full Text] [Related]
60. Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.
Chung J; Negm L; Bianchi V; Stengs L; Das A; Liu ZA; Sudhaman S; Aronson M; Brunga L; Edwards M; Forster V; Komosa M; Davidson S; Lees J; Tomboc P; Samuel D; Farah R; Bendel A; Knipstein J; Schneider KW; Reschke A; Zelcer S; Zorzi A; McWilliams R; Foulkes WD; Bedgood R; Peterson L; Rhode S; Van Damme A; Scheers I; Gardner S; Robbins G; Vanan MI; Meyn MS; Auer R; Leach B; Burke C; Villani A; Malkin D; Bouffet E; Huang A; Taylor MD; Durno C; Shlien A; Hawkins C; Getz G; Maruvka YE; Tabori U;
J Clin Oncol; 2023 Feb; 41(4):766-777. PubMed ID: 36240479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
